Ryan E. Lawrence, MD

Dr. Sonel Rowley is a neuropsychologist at PROMISE at Columbia. She provides comprehensive neuropsychological evaluations to underserved children and adolescents with learning, language, attention/executive function, and developmental disabilities. Dr. Rowley received her doctorate in school psychology from Fordham University. She completed her predoctoral internship in school pscyhology at The Bronxville School and her postdoctoral fellowship in pediatric neuropsychology at The Center for Attention and Learning at Lenox Hill Hospital. Throughout her clinical training, Dr. Rowley honed her skills in neuropsychological assessment by completing pediatric neuropsychology externships at Mt. Sinai Hospital, Lenox Hill Hospital and New York Presbyterian/Columbia University Medical Center. Further, Dr. Rowley’s master’s degree in therapeutic interventions has allowed her to become proficient in multiple evidence-based treatment interventions for children and adolescents with an array of mental health concerns.

Stanley Chang, M.D., is the former Edward S. Harkness Professor and Chairman of the Department of Ophthalmology at Columbia University Medical Center. He is also the K.K. Tse and Ku Teh Ying Professor of Ophthalmology. He is a specialist in vitreoretinal disorders and surgery and pioneered many of the surgical techniques currently used in this field. Dr. Chang received a B.S. degree from the Massachusetts Institute of Technology, a M.S. from the University of Pennsylvania, and completed his M.D. degree at the Vagelos College of Physicians and Surgeons of Columbia University. After a vitreoretinal surgery fellowship at the Bascom Palmer Eye Institute, Dr. Chang joined the faculty of Department of Ophthalmology at Cornell University Medical School, where he became Professor of Ophthalmology. Appointed the Edward S. Harkness Professor and Chairman of the Department of Ophthalmology in 1995, he served as director of the Edward S. Harkness Eye Institute until 2012. Dr. Chang has developed and pioneered several revolutionary surgical approaches to treat complicated forms of retinal detachment, improving outcomes for patients worldwide. He was the first to use perfluoropropane (C3F8) gas in the management of retinal detachments caused by scar tissue growth (PVR) on the retina. This gas is the most frequently used gas in complex vitreoretinal surgeries. He developed perfluorocarbon liquids, a 'heavy liquid' used in flattening retinal detachment, and changed the management of giant retinal tears and retinal detachments resulting from trauma globally. In collaboration with Avi Grinblat, he developed a panoramic viewing system and led in the worldwide adaptation by retina surgeons to this technique. Through research and innovation, he continues to improve the clinical outcomes for patients. He is the recipient of several honors including the Herman Wacker Prize from the Club Jules Gonin, Helmerich Prize from the American Society of Retina Specialists, the Lifetime Achievement Award and the Secretariat Award from the American Academy of Ophthalmology, the Edward Jackson Lecture, the Charles Schepens Lecture, the Donald M Gass Lecture, and the Jules Gonin Medal from the International Council of Ophthalmology. Consistently named as one of America's best doctors, Dr. Chang was also recognized as one of three physicians selected as National Physician of the Year by the Castle Connolly Guides in 2008. The Department of Ophthalmology is grateful to Dr. Chang for his exemplary and inspirational leadership during his time as Chair and Director of Ophthalmology. During his tenure, the department attracted a top-notch team of researchers and clinicians, developed new faculty practices in New York and New Jersey, more than doubled the number of surgical cases in the Eye Institute, and dramatically increased research funding. Dr. Chang remains an active member of the faculty and continues his patient care, research and teaching commitments.

Brian A. Fallon, MD, MPH, is the director of the Center for Neuroinflammatory Disorders and Biobehavioral Medicine and director of the Lyme and Tick-Borne Diseases Research Center at Columbia University. A graduate of Harvard College, he obtained his MD degree from the Columbia University College of Physicians and Surgeons, as well as a master's degree in public health epidemiology from Columbia University. He did his medical internship at Columbia University Medical Center and research training and an NIH fellowship in biological psychiatry at Columbia Presbyterian Medical Center and the New York State Psychiatric Institute.In addition to his work on illness anxiety, hypochondriasis, obsessive compulsive disorder, and somatoform disorders, Dr. Fallon is recognized internationally for his research on neurologic and neuropsychiatric Lyme disease. He has served on expert panels for the National Institutes of Health in different areas, including OCD and neurologic and chronic Lyme Disease, and has received over $10 million in both private and governmental grants to continue his research. He is the recipient of many awards, including the Laughlin Award from the American College of Psychiatrists, two commencement awards from the Columbia University College of Physicians and Surgeons (Richard Raynor Watson Award and the Titus Munson Coan Prize for best essay in Biomedical Research ("The Rise of Tuberculosis among the Homeless Mentally Ill"), the Columbia University Horwitz Award for excellence in Research, the Columbia Universit Medical Student Teacher of the Year award for psychiatry, a NARSAD Principal Investigator Award (2006), and the Roseke award from the American Psychiatric Association for outstanding teaching to medical students (2008). His major research interests cut across the boundaries of medicine, psychiatry, nuclear medicine and neurology.